Square Brussels Convention Centre

2024年3月12日 (火) 午前 9:00 - 2024年3月14日 (木) 午後 4:00

Glass Entrance, Mont des Arts/Kunstberg, 1000 Brussels, Belgium

DIA Europe 2024

Drug Repurposing: Opportunities & Challenges

Session Chair(s)

Tamara  Di Carlantonio, MA

Tamara Di Carlantonio, MA

Regulatory Policy Lead

Roche, Switzerland

Drug repurposing is regarded as a potential solution to treatment gaps and increasing healthcare costs, especially after COVID. However, this complex topic grants deeper discussion and a collaborative, multi-stakeholder approach.

Learning Objective : • Uncover the different aspects that come to play in drug repurposing: (including but not limited to) scientific, regulatory, patient access, healthcare systems, commercial • Articulate areas where repurposing presents opportunities • Describe current and potential challenges • Discuss how to tackle challenges in order to realize opportunities

Speaker(s)

Alberto  Ganan Jimenez, PhD

EMA Repurposing Pilot

Alberto Ganan Jimenez, PhD

European Medicines Agency, Netherlands

Head of Committees and Quality Assurance

Donald  Lo, PhD

Donald Lo, PhD

EATRIS, Netherlands

Director of Medicines Development

Guillaume  Canaud

Targeted Therapy in PIK3CA-Related Overgrowth Syndrome

Guillaume Canaud

Neckar Enfants Malades Hospital, France

Chief of the Overgrowth Syndromes and Vascular anomalies Unit

François  Houyez

Drug Repurposing: How to Proceed?

François Houyez

European Organisation for Rare Diseases (EURORDIS), France

Treatment Information and Access Director, Health Policy Advisor

Solange  Corriol-Rohou, DrMed, MD, PhD

Panelist

Solange Corriol-Rohou, DrMed, MD, PhD

AstraZeneca , France

Senior Director, Global Regulatory Affairs & Policy, R&D, Europe

Sini  Eskola, MPharm, MS, MSc

Panelist

Sini Eskola, MPharm, MS, MSc

EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium

Director Regulatory Strategy

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。